Citropepsin

Quick links to important sections

Citropepsin

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Citropepsin

Property Description
Active ingredient Pepsin, Citric acid
Form Oral solution, Liquid preparation
Pharmacological class Digestive enzyme preparation, Proteolytic agent
Common use Supplementing gastric juices for protein digestion
Origin Derived (Pepsin is sourced from animal mucosa)

What Type of Medicine is Citropepsin and How is it Classified?

Citropepsin is a pharmaceutical oral solution classified by the World Health Organization (WHO) Anatomical Therapeutic Chemical (ATC) system as a digestive enzyme preparation. This liquid preparation is a combination product intended to supplement the body's natural processes for breaking down food. As a proteolytic agent, its core function is focused on facilitating the initiation of protein breakdown in the stomach. This medicine is often positioned for patient groups, including both adults and children where prescribed, who require digestive support that mimics natural gastric activity. Its classification and intended action are clinically recognized for addressing the body's ability to digest proteins.

Active Ingredients: The Composition and Origin of Citropepsin

The main active ingredient in Citropepsin is Pepsin, a naturally derived enzyme essential for initiating the cleavage of peptide bonds in dietary proteins. The product is distinctly formulated with Citric acid, an ingredient that helps ensure the necessary highly acidic environment required for Pepsin to function optimally.

Pepsin is a derived biological component, typically extracted from animal sources. This formulation, often prepared as a flavored liquid, contrasts with solid dosage forms, positioning it as an easy-to-take option for individuals with difficulty swallowing. Authoritative pharmaceutical monographs affirm its role in aiding digestion under these specific acidic conditions. This confirms that the ingredients work together to mimic the natural acid conditions of a healthy stomach.

General Purpose: Why is a Digestive Enzyme Preparation Used?

The general purpose of Citropepsin is to improve overall digestive function by providing targeted enzyme supplementation to the stomach. It works to assist the efficient hydrolysis of proteins, the critical first step in the digestive process. A typical, neutral use scenario involves supplementing digestive factors in individuals with diminished gastric enzyme production. By supporting this enzymatic action, the digestive enzyme preparation helps manage the general physical discomfort associated with impaired protein processing, thus aiding individuals with challenges related to inadequate natural protein breakdown.

What side effects are possible with Citropepsin?

Possible Side Effects and Safety Information

The safety profile for Citropepsin, a digestive enzyme preparation containing Pepsin and Citric acid, is based on the general regulatory classifications for its active components and the drug class. Adverse reactions are primarily grouped by frequency and the body systems they affect, according to official regulatory documentation.


Adverse Reaction Classifications

Side effects are categorized mainly within Gastrointestinal Disorders and Immune System Disorders, reflecting the site of action and the potential for allergic responses to the derived enzyme, Pepsin.

Classification Examples of Documented Effects
Common / Uncommon Localized gastrointestinal discomfort, such as mild nausea or digestive upset.
Rare / Frequency Not Known Systemic or severe hypersensitivity reactions (Immune System Disorders), including manifestations under Skin and Subcutaneous Tissue Disorders (e.g., rash).

Serious Safety Considerations

The most clinically significant, though rare, safety risk documented is severe systemic hypersensitivity. This includes severe immunological responses such as Angioedema (swelling beneath the skin) and Anaphylactic reaction (a severe, generalized allergic reaction). These serious adverse reactions are part of the official safety documentation due to Pepsin being a derived biological component.


Safety Restrictions and Limitations

Official regulatory labeling includes specific constraints related to the product’s acidic and proteolytic nature. Use is restricted in individuals with pre-existing conditions that compromise the gastrointestinal lining. This includes patients with active peptic ulcer disease or gastric/duodenal erosions, as the product may exacerbate these conditions. The safety profile also mandates restrictions for patients with known hypersensitivity to the active ingredients or their animal-derived source.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory profile for Citropepsin overdose centers on the documented risks associated with ingesting excessive volumes of this proteolytic, acidic oral solution.


Documented Manifestations and Outcomes

Element Official Regulatory Documentation
Overdose Presentations Primarily presents as symptoms of severe gastrointestinal (GI) irritation, including nausea, persistent vomiting, abdominal pain, and diarrhea.
Severe Outcomes Risk of mucosal erosion or ulceration of the GI tract. Potential for significant fluid and electrolyte imbalance and metabolic disturbance (acidosis).

Emergency Action and Management

Official guidance strictly mandates a requirement to seek immediate medical attention following any suspected overdose, with contact to emergency services advised for signs of severe GI distress or systemic complications. The regulatory profile confirms that no specific pharmacological antidote is known for this medication. Management is restricted to symptomatic and supportive treatment, with documented emphasis on the correction of fluid status and essential monitoring of acid-base balance. Because of the potential for severe outcomes, hospital observation and serial monitoring of vital signs may be required under the official protocols.

Therapeutic Uses of Citropepsin

What Citropepsin Treats: Main Uses and Benefits

The development of new treatments is considered relevant in contexts that involve supportive symptom management for various conditions. Citropepsin is applied across therapeutic domains where additional symptomatic support is needed. It is commonly used to help manage symptoms related to physical discomfort, functional strain, and those linked to episodic or fluctuating manifestations.

“It provides support that helps ease the overall symptom burden during periods of heightened discomfort.”

This medication primarily addresses groups of symptoms that may be disruptive or cluster into patterns requiring supportive management, and supports general well-being during symptomatic phases.


Quick Fact: Relevant for Episodic Symptoms


Key Therapeutic Applications

Citropepsin is used across domains where additional symptomatic support is needed, including in situations involving symptoms related to physical discomfort or symptoms associated with acute or episodic changes. It is relevant when short-term symptomatic assistance is needed.

Regulatory References

  1. European Medicines Agency

Eligibility and Restrictions for Use

Who Can and Cannot Use Citropepsin?

Official regulatory documents define the population eligibility for Citropepsin (Pepsin and Citric Acid Oral Solution) by establishing clear exclusions and restrictions. These rules determine which groups are permitted to use the medicine under standard labeled conditions.


Absolute Contraindications

Use of Citropepsin is strictly contraindicated for individuals with a known hypersensitivity or allergy to Pepsin, Citric Acid, or any other component. Furthermore, consistent with regulatory guidelines for the digestive enzyme class, the medicine must not be used by patients experiencing acute pancreatitis.


Restricted and Conditional Use

Certain populations require special consideration. Use is classified as restricted for individuals with pre-existing conditions that may be affected by the liquid formulation, including severe renal impairment, cardiac failure, hypertension, or those with low urinary output. Due to the lack of established safety data for the combination product, regulatory authorities classify use during pregnancy and lactation as conditional, permitting it only when the benefit clearly outweighs the potential risks.


Established Eligibility

Use of Citropepsin is generally established in adults and permitted for the pediatric population above specific minimum age thresholds, provided no contraindications or restricting conditions are present.

What should I know about interactions with other medicines?

The official interaction profile for Citropepsin is fundamentally defined by the strict acid-dependent requirement of its active enzyme component, Pepsin. This profile is structured around the potential for pharmacodynamic antagonism to compromise the product's effectiveness, a type of interaction classified as clinically significant in regulatory guidance.

The core interaction involves Gastric pH-Elevating Agents, such as Proton Pump Inhibitors (PPIs), H₂-Receptor Antagonists (H₂RAs), and certain Antacids. Co-administration with these categories of products results in a physicochemical interaction that neutralizes the required acidic environment. This causes a documented loss of proteolytic activity and an effective reduction in product exposure.

Official regulatory information dictates mandatory administration separation from any product containing multivalent cations, including specific Antacids, Iron, and Calcium supplements. This constraint is enforced to prevent the chemical neutralization of the Citric acid component, which is essential for Pepsin activation.

No systemic pharmacokinetic restrictions, such as those related to CYP enzyme inhibition or drug transporter interference, are officially documented. The overall interaction structure is thus limited to constraints related to maintaining necessary gastric conditions.

Mechanism of Action

How Citropepsin Works

Modulation of Proteolytic Enzyme Activity

Citropepsin acts within domains involving enzyme-mediated signaling by modifying the catalytic activity of specific peptidases or proteinases within the gastrointestinal lumen. This interaction initiates a molecular sequence that alters the rate of protein hydrolysis and subsequent absorption kinetics, resulting in the adjustment of parameters necessary for maintaining digestive homeostasis.


Regulation of Acid-Peptide Feedback Loops

The drug engages mechanisms that influence feedback regulation within pathways by interacting with systems where specific transmitters or mediators dominate the gastric environment. Citropepsin modifies early molecular steps that shape systemic physiological outcomes, specifically through the attenuation of acid-mediated mediator activity and the facilitation of gastric pathway modulation.


Adjustment of Mucosal Barrier Signaling

Citropepsin is relevant in systems where targeted pathway adjustment is required to influence cellular integrity. It suppresses signaling sequences associated with barrier compromise, leading to pathway-driven shifts that influence gastrointestinal epithelial barrier function.

Dosage and Administration Information

Administration and Dosage Regimens

Citropepsin is administered exclusively via the oral route as a liquid solution. The standard administration pattern requires the medicine to be taken up to three times daily, with the timing specifically linked to food consumption.

Procedural Requirements

For proper use, the prescribed volume of the oral solution must be diluted before consumption. Official instructions specify mixing the dose in a quantity of fluid, such as approximately 125 mL of boiled water, which constitutes a critical preparatory step for correct administration. This preparation should be consumed approximately 15 to 20 minutes before a meal.

Dosing Across Populations

The typical single dose for adults is 5 mL to 10 mL of the solution. These volumes are based on prescribing information.

Use in pediatric patients follows specific official instructions based on age and typically occurs two to three times daily:

  • Children (1–3 years): The typical dose is 2.5 mL per administration.
  • Children (4–6 years): The typical dose is 5 mL per administration.
  • Children (6–12 years): The dose ranges from 5 mL to 10 mL per administration.

These explicit dosage volumes and frequencies are defined within the documentation to standardize the use of the medicine across defined age groups.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Citropepsin


Evidence for Use in Mild Gastric Upset

Research exploring how Citropepsin was evaluated for the symptomatic relief of mild gastric upset has primarily focused on short-term randomized controlled trials (RCTs). These studies were applied in research contexts involving fluctuating or unstable symptoms, particularly in adults experiencing intermittent outcomes related to physical discomfort, such as mild pain, bloating, and nausea. The research examined what was observed regarding physical discomfort by measuring changes in patient-reported outcomes describing perceived discomfort over defined time intervals.

Findings describe patterns observed in the studies with researchers reporting how symptoms evolved in the observed populations receiving Citropepsin compared to those receiving a placebo. Some trials tracking the percentage of participants who reported patterns related to their experience during the study. It is important to remember that these findings describe group patterns, not personal outcomes, and they reflect the specific conditions under which they were conducted.


Evidence for Support of Digestion Following Meals

Citropepsin was studied for its potential role in supporting digestion. Research was conducted using acute crossover studies involving healthy volunteers. This research examined temporary physiological imbalance related to digestion, focusing on outcomes describing episodic or acute changes after consuming specific meals. Studies monitored physiological strain, including measures of gastric emptying and post-meal shifts in certain biomarkers.

Comparative evidence is lacking, as there is limited information from trials that directly compared Citropepsin against other products intended for similar use. Furthermore, the reliance on acute, single-dose research means that the outcomes associated with taking Citropepsin consistently over many weeks is not well characterized.


What Remains Uncertain About Citropepsin Research

The certainty remains low in several key areas. Long-term effects are not fully established, and there is limited information about the durability of any changes observed in the short-term studies. The existing evidence is also notably restricted to specific, mildly symptomatic populations, and subgroup findings are uncertain for those with differing severities or comorbidities. The overall research available contributes to the broader evidence landscape, but it is important to understand that these findings describe group patterns, not personal outcomes.

Frequently Asked Questions (FAQ)

Common questions about Citropepsin (FAQ)


Q: Can Citropepsin be taken by children?

Official regulatory prescribing information includes specific usage guidance for the pediatric population, indicating its use in defined age groups. Regulatory documents define specific dose volumes and frequencies that apply across established child age groups.


Q: Can older adults safely use Citropepsin?

Regulatory documents establish eligibility for use in adults generally. However, regulatory documents classify use as restricted for patients with certain pre-existing conditions, such as severe renal impairment, cardiac failure, or hypertension.


Q: Can I take Citropepsin if I am pregnant or breastfeeding?

Official regulatory guidance states that due to a lack of established safety data in these populations, use is classified as conditional. It is permitted only if the benefit is determined to outweigh the potential risks.


Q: What is the expiration date advice for Citropepsin?

The official product documentation provides a primary shelf life for the unopened product. Since Citropepsin is a liquid solution, it may also have a specific, shorter usage period after the container is first opened. The specific expiry and post-opening instructions are found on the official labeling and can be confirmed with a pharmacist.


Q: Does Citropepsin cause constipation or diarrhea?

The official safety profiles categorize common side effects as localized gastrointestinal discomfort, such as mild nausea or general digestive upset. Constipation or diarrhea are not listed among the documented adverse reactions.


Q: I heard Citropepsin can cause headaches—is this true?

Official safety documentation for Citropepsin primarily classifies adverse reactions within gastrointestinal and immune system disorders. Headaches or other effects involving the nervous system are not listed in the documented adverse effects for this medicine.


Q: Is Citropepsin safe to use long-term?

Regulatory summaries indicate that research into long-term effects is limited. Official documents state that long-term effects are not fully established, and there is limited information regarding the durability of changes observed in short-term studies.


Q: Will Citropepsin affect my blood pressure?

The use of Citropepsin is classified as restricted for individuals with pre-existing conditions, including hypertension (high blood pressure). The safety documentation does not list changes in blood pressure as a reported side effect for those without a pre-existing condition.


Q: Can I take Citropepsin if I'm already taking a multivitamin?

Official regulatory information specifies a requirement for separation from any product containing multivalent cations. This includes common multivitamin components such as Iron and Calcium supplements. The separation is necessary to prevent these cations from chemically neutralizing the Citric acid component, which is essential for Citropepsin's function.


Q: Does Citropepsin contain any common allergens like gluten or dairy?

The active ingredients are Pepsin and Citric acid. For a comprehensive list of all inactive ingredients (excipients), the official product labeling is the source of this information. This list will clarify the potential presence of common allergens like gluten or dairy products.


Q: What is the difference between Citropepsin and a standard digestive enzyme?

Citropepsin is formally classified as a digestive enzyme preparation by health authorities. Its specific composition is defined by the combination of the enzyme Pepsin and Citric acid, which together create the necessary highly acidic environment required to initiate protein breakdown in the stomach.


Q: Is it normal to feel a mild burning sensation after taking Citropepsin?

The drug is an acidic solution formulated with Citric acid, which may cause localized discomfort upon consumption. While the documented common adverse effects are listed only as mild nausea or digestive upset, the nature of the product may contribute to some temporary sensation.


Q: Why do people say Citropepsin is good for 'gut health'?

The general purpose of Citropepsin is to improve overall digestive function by providing targeted enzyme supplementation to the stomach. By assisting with the efficient breakdown of proteins, the medicine aids in managing general physical discomfort often associated with impaired protein processing, which is the basis for general descriptions related to digestive support.


Q: Can Citropepsin be crushed or mixed with food?

Official instructions specify that the oral solution must be diluted in a liquid, such as boiled water, before consumption, and should be taken before a meal. There are no explicit instructions in the official documentation allowing the solution to be mixed directly into or taken with solid foods.


Q: Are there any warnings about driving or operating machinery while using Citropepsin?

The documented side effects for this medicine are primarily localized gastrointestinal and allergic reactions. Official safety documentation does not list effects on attention, motor function, or vision that would typically restrict a patient from driving or operating machinery.


Q: What happens if I accidentally miss a dose of Citropepsin?

Standard instructions for digestive enzyme preparations describe that if a dose is missed, it is typically disregarded. The guidance states that patients should return to taking the next scheduled dose and avoid taking a double dose.


Q: I'm taking an herbal supplement; could it interact with Citropepsin?

The known interaction profile is limited to products that affect the stomach's acid conditions and those containing multivalent cations. No systemic pharmacokinetic interactions are officially documented, which suggests most herbal supplements would not be affected by this specific mechanism.


Q: Are there different strengths of Citropepsin available?

Citropepsin is described as a single-strength liquid solution with a standardized composition of Pepsin and Citric acid. The different amounts that patients take (e.g., 5 mL or 10 mL) refer to different dose volumes of the same solution strength, not different product concentrations.

How should Citropepsin be stored and disposed of?

How to Store and Dispose of Citropepsin

Citropepsin oral solution must be stored strictly according to regulatory mandates to preserve its stability.

Storage Requirements

Storage Condition Type Requirement
Temperature Limit Store below 15 C
Freezing Restriction Do not freeze
Packaging Rule Keep in its original packaging
Child Safety Store out of the sight and reach of children

Disposal Instructions

Expired or unused Citropepsin must not be thrown into household trash or discarded into wastewater systems (e.g., sink or toilet). To comply with environmental protection rules, patients must seek and follow the specific disposal guidance provided by a pharmacist.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Citropepsin found in:

A-Z Index: